Telix Pharmaceuticals Ltd. (TLX)

9.51 +0.25 (+2.70%) USD  |  NASDAQ  |  Oct 29, 16:00
9.51 0.00 (0.00%) After-Hours: 16:46
More

Telix Pharmaceuticals EV to CFO

EV to CFO Chart

View EV to CFO for TLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to CFO Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 --
December 31, 2025 --
Date Value
June 30, 2025 --
December 31, 2024 --

EV to CFO Range, Past 5 Years

View EV to CFO Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to CFO Benchmarks

View EV to CFO Benchmarks
Start Trial
Mesoblast Ltd. Upgrade
Immutep Ltd. --
CSL Ltd. --
Ceryvyn Therapeutics Ltd. --
Propanc Biopharma, Inc. Upgrade

EV to CFO Related Metrics

EV to EBITDA Upgrade
EV to Revenues Upgrade
EV to Free Cash Flow Upgrade
EV to Earnings Upgrade